Photo-oxidative action in MCF-7 cancer cells induced by hydrophobic cyanines loaded in biodegradable microemulsion-templated nanocapsules

International Journal of Oncology

Volumn 41, Issue 1, 2012, Pages 105-116

  Wilk, Kazimiera A ^a   Zielińska, Katarzyna ^a   Pietkiewicz, Jadwiga ^b   Skołucka, Nina ^b   Choromańska, Anna ^b   Rossowska, Joanna ^c   Garbiec, Arnold ^d   Saczko, Jolanta ^b  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^d UNIVERSITY OF WROC AW   (Poland)

Author keywords

Cyanine; Lipid peroxidation; Nanocarriers; Oxidative protein damage; Photodynamic therapy

Indexed keywords

CYANINE DYE; IR 780; NANOCAPSULE; NANOCARRIER; NANOPARTICLE; PHOTOSENSITIZING AGENT; POLY(N BUTYL CYANOACRYLATE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; ATOMIC FORCE MICROSCOPY; BIOAVAILABILITY; BIODEGRADABILITY; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ENCAPSULATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HYDROPHOBICITY; LIPID PEROXIDATION; MICROEMULSION; OXIDATIVE STRESS; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTOOXIDATION; PRIORITY JOURNAL;

CELL LINE, TUMOR; CELL SURVIVAL; CYANOACRYLATES; DRUG STABILITY; EMULSIONS; HUMANS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; INDOLES; MALONDIALDEHYDE; NANOCAPSULES; NEOPLASMS; OXIDATION-REDUCTION; OXIDATIVE STRESS; PARTICLE SIZE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SULFHYDRYL COMPOUNDS; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 84862847345     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2012.1458     Document Type: Article

References (50)

1. Celli JP, Spring BQ, Rizvi I, Evans CL, Samokoe KS, Verma S, Pogue BW and Hasan T: Imaging and photodynamic therapy: mechanism, monitoring, and optimization. Chem Rev 110: 2795-2838, 2010.
2. Allison RR, Bagnato VS, Cuenca R, Dovnie GH and Sibata CH: The future of photodynamic therapy in oncology. Future Oncol 2: 53-71, 2006.
3. Saczko J, Kulbacka J, Chwiłkowska A, Ługowski M and Banaś T: Levels of lipid peroxidation in A549 cells after PDT in vitro. Proc Ann Acad Med Bialostoc 49: 82-84, 2004.
4. Castano AP, Demidova TN and Hamblin MR: Mechanisms in photodynamic therapy: part two - cellular, cell metabolism and modes of cell death. Photodiag Photodyn Ther 2: 1-23, 2005. (Pubitemid 40805368)
5. Oleinick NL, Morris RL and Belichenko I: The role of apoptosis in response to photodynamic therapy: what, where, why, and how. Photochem Phtobiol Sci 1: 1-21, 2002. (Pubitemid 37069701)
6. Castano AP, Demidova TN and Hamblin MR: Mechanisms in photodynamic therapy: part one - photosensitizers, photochemistry and cellular localization. Photodiagn Photodyn Ther 1: 279-293, 2004. (Pubitemid 40460316)
7. Kassab K: Photophysical and photosensitizing properties of selected cyanines. J Photochem Photobiol B 68: 15-22, 2002.
8. Kulbacka J, Pola A, Mosiadz D, Choromanska A, Nowak P, Kotulska M, Majkowski M, Hryniewicz-Jankowska A, Purzyc L and Saczko J: Cyanines as efficient photosensitizers in photodynamic reaction: photophysical properties and in vitro photodynamic activity. Biochemistry (Moscow) 76: 473-479, 2011.
9. Santos PF, Reis LV, Almeida P, Oliviera AS and Vieira Ferreira LF: Singlet oxygen generation ability of squarylium cyanine dyes. J Photochem Photobiol A 160: 159-161, 2003.
10. Nowak-Sliwinska P, Karocki A, Elas M, Pawlak A and Stochel G: Verteporfin, photofrin II, and merocyanine 540 as PDT photosensitizers against melanoma cells. Biochem Biophys Res Commun 349: 549-555, 2006. 0
11. Breunig M, Bauer S and Goepferich A: Polymers and nanoparticles: intelligent tools for intracellular targeting. Eur J Pharm Biopharm 68: 112-128, 2008. (Pubitemid 350181412)
12. Cho K, Wang X, Nie S, Chen ZG and Shin DM: Therapeutic nanoparticles for drug delivery in cancer. Clin Cancer Res 14: 1310-1316, 2008. (Pubitemid 351413909)
13. Torchilin VP: Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J 9: 128-147, 2007.
14. Guterres SS, Alves MP and Pohlmann AR: Polymeric nanoparticles, nanospheres and nanocapsules, for cutaneous applications. Drug Target Insights 2: 147-157, 2007.
15. Johnston APR, Cortez C, Angelatos AS and Caruso F: Layer-by-layer engineered capsules and their applications. Curr Opin Colloid Interface Sci 11: 203-209, 2006. (Pubitemid 44738642)
16. Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H and Couvreur P: Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Deliv Rev 55: 519-548, 2003. (Pubitemid 36423302)
17. Pietkiewicz J, Zielińska K, Saczko J, Kulbacka J, Majkowski M and Wilk KA: New approach to hydrophobic cyanine-type photosensitizer delivery using polymeric oil-cored nanocarriers: hemolytic activity, in vitro cytotoxicity and localization in cancer cells. Eur J Pharm Sci 39: 322-335, 2010.
18. Lambert G, Fattal E, Pinto-Alphandary H, Gulik A and Couvreurr P: Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for delivery of oligonucleotides. Pharm Res 17: 707-714, 2000. (Pubitemid 30670637)
19. Li YP, Pei YY, Zhou ZH, Zhang XY, Gu ZH, Ding J, Zhou JJ, Gao XJ and Zhu JH: Stealth polycyanoacrylate nanoparticles as tumor necrosis factor-carriers: pharmacokinetics and anti-tumor effects. Biol Pharm Bull 24: 662-665, 2001. 0
20. Graf A, Ablinger E, Peters S, Zimmer A, Hook S and Rades T: Microemulsions containing lecithin and sugar-based surfactants: nanoparticle templates for delivery of proteins and peptides. Int J Pharm 350: 351-360, 2008.
21. Graf A, Rades T and Hook SM: Oral insulin delivery using nanoparticles based on microemulsions with different structure-types: optimization and in vivo evaluation. Eur J Pharm Sci 37: 53-61, 2009.
22. Wilk KA, Zielińska K, Pietkiewicz J and Saczko J: Loaded nanoparticles with cyanine-type photosensitizers: preparation, characterization and encapsulation. Chem Eng Trans 17: 987-992, 2009.
23. Wilk KA, Syper L, Burczyk B, Sokołowski A and Domagalska BW: Synthesis and surface properties of new dicephalic saccharide-derived surfactants. J Surfact Det 3: 185-192, 2000. (Pubitemid 32182942)
24. Komorek U and Wilk KA: Surface and micellar properties of new non-ionic gemini aldonamide-type surfactants. J Colloid Interface Sci 271: 206-211, 2004. (Pubitemid 38147620)
25. Wilk KA, Laska U, Zielińska K and Olszowski A: Fluorescence probe studies upon microenvironment characteristics and aggregation properties of gemini sugar surfactants in an aquatic environment. J Photochem Photobiol A 219: 204-210, 2011.
26. Wilk KA, Syper L, Domagalska BW, Komorek U, Maliszewska I and Gancarz R: Aldonamide-type gemini surfactants: synthesis, structural analysis and biological properties. J Surfact Det 5: 235-244, 2002.
27. Wilk KA, Zielińska K, Hamerska-Dudra A and Jezierski A: Biocompatible microemulsions of dicephalic aldonamide-type surfactants: formulation, structure and temperature influence. J Colloid Interface Sci 334: 87-95, 2009.
28. Delaey E, van Laar F, De Vos D, Kamuhabwa A, Jacobs P and De Witte PA: Comparative study of the photosensitizing characteristics of some cyanine dyes. J Photochem Photobiol B 55: 27-36, 2000. (Pubitemid 30311694)
29. Saczko J, Skrzypek W, Chwiłkowska A, Choromańska A, Poła A, Gamian A and Kulbacka J: Photo-oxidative action in cervix carcinoma cells induced by HpD-mediated photodynamic therapy. Exp Oncol 31: 195-199, 2009.
30. Ying X, Wen H, Lu WL, Du J, Guo J, Tian W, Men Y, et al: Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals. J Control Release 141: 183-192, 2010.
31. Da Silva AR, Inada NM, Rettori D, Baratti MO, Vercesi AE and Jorge RA: In vitro photodynamic activity of chloro (5,10,15,20-tetraphenylporphyrinato) indium(III) loaded-poly (lactide-co-glycolide) nanoparticles in LNCaP prostate tumour cells. J Photochem Photobiol B 94: 101-112, 2009.
32. Kulbacka J, Bar J, Chwilkowska A, Dumanska M, Drag-Zalesinska M, Wysocka T, Stach K, et al: Oxidative modulation of marcaine and lekoptin in H9C2 rat myoblasts. Acta Pharmacol Sin 30: 184-192, 2009.
33. Subramanian N, Ghosal SK, Acharya A and Moulik SP: Formulation and physicochemical characterization of microemulsion system using iso-propyl myristate, medium-chain glyceride, polysorbate 80 and water. Chem Pharm Bull 53: 1530-1535, 2005. (Pubitemid 41744477)
34. Wilson BC and Patterson MS: The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 5: 61-109, 2008.
35. Castano AP, Mroz P and Hamblin MR: Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 6: 535-545, 2006. (Pubitemid 43980542)
36. Wilk KA, Zielinska K, Jarzycka A and Pietkiewicz J: Human erythrocyte hemolysis induced by bioinspired sugar surfactants. Progr Colloid Polym Sci 138: 189-192, 2011.
37. Zielinska K, Pietkiewicz J, Saczko J and Wilk KA: Microemulsion stabilized by gemini, dicephalic and single-head single tail sugar surfactants as biologically important systems: hemolytic activity and cytotoxic studies. Progr Colloid Polym Sci 138: 193-196 2011.
38. Müller RH, Jacobs C and Kayser O: Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future. Adv Drug Deliv Rev 47: 3-19, 2001. (Pubitemid 32209229)
39. Haillaireau H and Couvreur P: Nanocarriers' entry into the cell: relevance to drug delivery. Cell Mol Life Sci 66: 2873-2896, 2009.
40. Panyam J, Sahoo SK, Prabha S, Bargar T, Labhasetwar V: Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D, L-lactide-co-glycolide) nanoparticles. Int J Pharm 262: 1-11, 2003. (Pubitemid 36966688)
41. Win KY and Feng SS: Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 26: 2713-2722, 2005.
42. Yordanov G, Abrashev N and Dushkin C: Poly(n-butylcyanoacrylate) submicron particles loaded with ciprofloxacin for potential treatment of bacterial infections. Progr Colloid Polym Sci 137: 53-59, 2010.
43. Han A, Yang L and Frazier AB: Quantification of the heterogeneity in breast cancer cell lines using whole-cell impedance spectroscopy. Clin Cancer Res 13: 139-143, 2007. (Pubitemid 46121862)
44. Konemann S, Schuck A, Malath J, Rupek T, Horn K, Baumann M, Vormoor J, et al: Cell heterogeneity and subpopulations in solid tumors characterized by simultaneous immunophenotyping and DNA content analysis. Cytometry 41: 172-177, 2000.
45. Chaudhery V, Lu M, Huang CS, George S and Cunningham BT: Photobleaching on photonic crystal enhanced fluorescence surfaces. J Fluoresc DOI 10.1007/s10895-010-0760-8, 2010.
46. Ai H, Pirk JJ, Shuai X, Boothman DA and Gao J: Interaction between self-assembled polyelectrolyte shells and tumor cells. Biomed Mater Sci 73: 303-312, 2005. (Pubitemid 40664296)
47. Skřivanová K, Škorpíková J, Švihálek J, Mornstein V and Janich R: Photochemical properties of a potential photosensitiser indocyanine green in vitro. J Photochem Photobiol B 85: 150-154, 2006. (Pubitemid 44542578)
48. Konan YN, Gurny R and Allemann E: State of the art in the delivery of photosensitizers for photodynamic therapy. J Photochem Photobiol B 66: 89-106, 2002. (Pubitemid 34240266)
49. Zajdel A, Latocha M and Wilczok A: The effect of photodynamic treatment on the levels of aldehydic lipid peroxidation products in human tumor cell. Adv Clin Exp Med 17: 599-605, 2008.
50. Nowis D, Makowski M, Stokłosa M, Legat M, Issat T and Goła̧b J: Direct tumor damage mechanisms of photodynamic therapy. Acta Biochim Pol 52: 339-352, 2005.